Candriam Luxembourg S.C.A. »

Summit Therapeutics shares owned by Candriam Luxembourg S.C.A.

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Candriam Luxembourg S.C.A. from 13F filings

Historical chart of Candriam Luxembourg S.C.A. investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Candriam Luxembourg S.C.A. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Candriam Luxembourg S.C.A.

Quarter filed Position value Share count Share price at filing
2025-09-30 $11M 514k 20.66
2025-06-30 $11M 514k 21.28
2025-03-31 $17M 839k 20.67
2024-12-31 $15M 843k 17.83
2024-09-30 $19M 850k 21.90